Overview

Assessment of Safety and Efficacy of Therapy for the Prevention of Weight Gain Associated With Olanzapine

Status:
Completed
Trial end date:
2008-09-01
Target enrollment:
Participant gender:
Summary
The goal of this study is to answer the following questions: - Whether treatment with amantadine, metformin or zonisamide can prevent or reverse the weight gain that is associated with olanzapine - Whether taking amantadine, metformin or zonisamide can help patients decrease or eliminate some of the changes in body that occur with weight gain - How weight gain associated with olanzapine can affect people - Whether treatment with amantadine, metformin or zonisamide can help eliminate weight gain associated with olanzapine and not interfere with the positive effects of olanzapine on functioning of people with schizophrenia and other diseases
Phase:
Phase 3
Details
Lead Sponsor:
Eli Lilly and Company
Treatments:
Amantadine
Metformin
Olanzapine
Zonisamide